+ Watch OMED
on My Watchlist
High Risk but has Hugh Potential--5 to 10x. Backed by Celgene.
Got in on tail end of this IPO and paid on the high end. Have to admit I have been biting my fingernails a little bit on this one. I do believe that with patience this one will pay off. With interest from GSK and Bayer I do believe they will be a good investment in due time.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions